How to keep a GLP-1 side effect diary
A GLP-1 side effect diary is one line per symptom: what it was, when it started counted from your last injection, how bad it was, how long it lasted, what you had eaten or drunk beforehand, and what helped. Written on the day, it shows patterns, such as nausea on the second evening after every shot, that you and your prescriber can act on. The FDA labels for semaglutide and tirzepatide list nausea, vomiting, diarrhea, constipation and stomach pain among the most common side effects, and their Medication Guides list warning signs that mean calling your healthcare provider or getting medical help straight away. Both are set out below.
This guide is about the record. It does not tell you how to treat a side effect or whether to keep using your medicine; those are questions for your prescriber.
What should each diary entry include?
| Field | What to write | Example |
|---|---|---|
| Symptom | Plain words, one symptom per line | Nausea |
| Started | Date, time and days since the injection | Thursday 8 pm, day 2 |
| Severity | One scale, used the same way every time | Moderate |
| Duration | When it stopped, or "ongoing" | About 6 hours |
| Before it | What you ate and drank in the hours before | Large takeaway, little water |
| What you did | Anything you tried, and whether it helped | Lay down, eased by morning |
| Effect on your day | Anything you could not do | Skipped dinner |
| Dose context | The amount you were on and the site | As prescribed, abdomen left |
The last field matters more than it looks. If your prescriber changes the dose, or you start a new pen or vial, the diary shows whether a symptom began after the change.
How should you rate severity?
Pick one scale and keep it. Three words are enough:
| Rating | Meaning |
|---|---|
| Mild | You noticed it, but it did not stop anything you planned |
| Moderate | It limited some of what you planned to do |
| Severe | It stopped your normal day |
A 0 to 10 number works too, if you prefer it. What matters is that "moderate" in week 1 means the same as "moderate" in week 6, so the entries can be compared.
Why count the days from the injection?
GLP-1 injections such as Ozempic, Wegovy, Mounjaro and Zepbound are used once a week, so every symptom falls somewhere in a seven-day cycle. Call the injection day "day 0" and write the day number with each entry. After a few weeks the diary answers questions that memory cannot:
- Does it start on the same day after each shot?
- Is it shorter or milder now than in the first week?
- Did it start after a dose change, a new pen or a new vial?
- Does it follow a particular kind of meal?
What does a side effect diary look like?
| Date (day) | Symptom, severity | Lasted | Before it | What helped |
|---|---|---|---|---|
| Mon 3 Nov (day 1) | Nausea, mild | 3 hours | Normal lunch | Nothing needed |
| Tue 4 Nov (day 2) | Nausea, moderate | 6 hours | Large, fatty dinner | Lay down |
| Thu 6 Nov (day 4) | Constipation, mild | 2 days | Low fluids | Not sure |
| Mon 10 Nov (day 1) | Nausea, mild | 2 hours | Smaller lunch | Nothing needed |
Write the entry the same day. Recalled at the appointment, "some stomach trouble early on" has lost the timing and the severity that make it useful. If you are early in treatment, what to track in your first month on a GLP-1 puts the diary alongside the dose log and weekly weight.
Which side effects do the FDA labels list as most common?
Each label lists the adverse reactions reported in 5% or more of patients in its clinical trials. In plain words:
| Medicine | Most common side effects |
|---|---|
| Ozempic (semaglutide) | Nausea, vomiting, diarrhea, stomach (abdominal) pain, constipation |
| Wegovy (semaglutide) | Nausea, diarrhea, vomiting, constipation, stomach pain, changes in skin sensation, headache, tiredness, upset stomach, dizziness, bloating, belching, low blood sugar in people with type 2 diabetes, gas, stomach flu, heartburn, hair loss |
| Mounjaro (tirzepatide) | Nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, stomach pain |
| Zepbound (tirzepatide) | Nausea, diarrhea, vomiting, constipation, stomach pain, indigestion, injection site reactions, tiredness, allergic reactions, belching, hair loss, heartburn |
These are not all the possible side effects, as each Medication Guide says. Log anything you notice, whether it is on the list or not, and let your prescriber decide whether it is related. For compounded semaglutide and tirzepatide, FDA says many of the adverse events reported to it appear consistent with those of the approved versions.
All four Medication Guides say to talk to your healthcare provider about any side effect that bothers you or does not go away.
Which warning signs mean calling your prescriber or getting help?
The Medication Guides list these serious side effects. The wording below is from the Ozempic Medication Guide; the Wegovy, Mounjaro and Zepbound guides use very similar wording with their own name. Read the guide that came with your medicine.
"Stop using OZEMPIC and get medical help right away" for symptoms of a serious allergic reaction:
- "swelling of your face, lips, tongue or throat"
- "problems breathing or swallowing"
- "severe rash or itching"
- "fainting or feeling dizzy"
- "very rapid heartbeat"
"Stop using OZEMPIC and call your healthcare provider right away" if you have "severe pain in your stomach area (abdomen) that will not go away, with or without vomiting. You may feel the pain from your abdomen to your back."
"Tell your healthcare provider right away" about:
- "nausea, vomiting, or diarrhea that does not go away"
- symptoms of gallbladder problems: "pain in your upper stomach (abdomen)", "yellowing of skin or eyes (jaundice)", "fever", "clay-colored stools"
"Tell your healthcare provider" about:
- "stomach problems that are severe or will not go away"
- "a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath"
- "changes in vision"
Two more from the other guides:
- The Wegovy Medication Guide says: "Tell your healthcare provider if you feel your heart racing or pounding in your chest and it lasts for several minutes."
- All four describe a higher risk of low blood sugar when the medicine is used with another that can cause it, such as insulin or a sulfonylurea (the Wegovy guide says this for people with type 2 diabetes), and list its signs, including dizziness, sweating, confusion, shakiness, fast heartbeat and hunger.
And if too much was injected, the Ozempic, Mounjaro and Zepbound Medication Guides say: "call your healthcare provider or Poison Help line at 1-800-222-1222 or go to the nearest hospital emergency room right away." The Wegovy guide says the same.
These are for acting on, not for saving until the next appointment. Get help first; write the entry afterwards, including what you did and what you were told.
Can you report a side effect to FDA yourself?
Yes. In the US, patients can report side effects directly to FDA through MedWatch or by calling 1-800-FDA-1088, the number printed in each Medication Guide. A diary entry with dates, severity and the product's lot number makes the report quicker to fill in.
Doing it in PeptideMate
Side effects can be recorded with each dose in the dose log, and the Progress tab summarises the ones logged in the last 30 days next to your weight and check-ins. Before an appointment, export the history as a CSV and add your questions; what to share with your doctor has the checklist. On paper, the GLP-1 tracker template has a side effect column.
Common questions
Should I record side effects that seem minor?
Yes. A mild symptom that turns up on the same day after every shot is a pattern, and you only see it if each one was written down.
Can an app tell me whether a side effect is serious?
No. PeptideMate records what you enter and does not interpret it. Use the Medication Guide's warning signs above, and get medical help for anything severe or worrying.
What if I changed vials or pharmacies before the side effect started?
Note it in the diary with the new lot number and concentration. How to log a compounded GLP-1 vial explains what to record when a vial changes.
Sources
- Ozempic (semaglutide) injection: prescribing information and Medication Guide, Novo Nordisk, via DailyMed (US National Library of Medicine), revised May 2026.
- Wegovy (semaglutide) injection and tablets: prescribing information and Medication Guide, Novo Nordisk, via DailyMed (US National Library of Medicine), revised June 2026.
- Mounjaro (tirzepatide) injection: prescribing information and Medication Guide, Eli Lilly and Company, via DailyMed (US National Library of Medicine), revised August 2026.
- Zepbound (tirzepatide) injection: prescribing information and Medication Guide, Eli Lilly and Company, via DailyMed (US National Library of Medicine), revised August 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss, US Food and Drug Administration, content current as of 1 October 2026.
- MedWatch: the FDA safety information and adverse event reporting program, US Food and Drug Administration.
This guide is about record keeping and unit arithmetic. It is not medical advice. See the medical disclaimer.